For: | Onodera M, Nishigami T, Torii I, Sato A, Tao LH, Kataoka TR, Yoshikawa R, Tsujimura T. Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC. World J Gastrointest Oncol 2009; 1(1): 69-73 [PMID: 21160777 DOI: 10.4251/wjgo.v1.i1.69] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v1/i1/69.htm |
Number | Citing Articles |
1 |
An Huang, Yong Yang, Jing-Yi Shi, Yu-Kun Li, Jing-Xuan Xu, Yu Cheng, Jin Gu. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World Journal of Gastrointestinal Surgery 2021; 13(12): 1567-1583 doi: 10.4240/wjgs.v13.i12.1567
|
2 |
Hong Kyu Lee, Mi Jung Kwon, Jinwon Seo, Jeong Won Kim, Mineui Hong, Hye-Rim Park, Soo Kee Min, Ji-Young Choe, Yong Joon Ra, Seung Hun Jang, Yong Il Hwang, Ho Young Kim, Kyueng-Whan Min. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer. Pathology - Research and Practice 2019; 215(3): 459 doi: 10.1016/j.prp.2018.12.011
|
3 |
Hye Lee, Dae Hwang, Hye Han. Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea. Oncology Letters 2020; 20(1): 655 doi: 10.3892/ol.2020.11606
|
4 |
Michael D Walsh, Mark Clendenning, Elizabeth Williamson, Sally-Ann Pearson, Rhiannon J Walters, Belinda Nagler, David Packenas, Aung K Win, John L Hopper, Mark A Jenkins, Andrew M Haydon, Christophe Rosty, Dallas R English, Graham G Giles, Michael A McGuckin, Joanne P Young, Daniel D Buchanan. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Modern Pathology 2013; 26(12): 1642 doi: 10.1038/modpathol.2013.101
|